I agree that this site is using cookies. You can find further informations here.
X
Flores-Chávez, Alejandra
1543  results:
Search for persons X
?
1

Temporal relationship between sarcoidosis and malignancies ..:

Brito-Zerón, Pilar ; Flores-Chávez, Alejandra ; González-de-Paz, Lluís...
Postgraduate Medical Journal.  , 2024
Link: https://doi.org/10.1093/..
 
?
2

Mortality risk factors in primary Sjögren syndrome: a real-..:

Brito-Zerón, Pilar ; Flores-Chávez, Alejandra ; Horváth, Ildiko Fanny...
eClinicalMedicine.  61 (2023)  - p. 102062 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Immune-related adverse events of cancer immunotherapies tar..:

Ramos-Casals, Manuel ; Flores-Chávez, Alejandra ; Brito-Zerón, Pilar..
Pharmacology & Therapeutics.  237 (2022)  - p. 108250 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Haemophagocytic syndrome and COVID-19:

Retamozo, Soledad ; Brito-Zerón, Pilar ; Sisó-Almirall, Antoni...
Clinical Rheumatology.  40 (2021)  4 - p. 1233-1244 , 2021
Link: https://doi.org/10.1007/..
 
?
5

Prognostic Factors of Death in 151 Adults With Hemophagocyt..:

Brito-Zerón, Pilar ; Kostov, Belchin ; Moral-Moral, Pedro...
Mayo Clinic Proceedings: Innovations, Quality & Outcomes.  2 (2018)  3 - p. 267-276 , 2018
Link: https://doi.org/10.1016/..
 
?
6

Cytokines as therapeutic targets in primary Sjögren syndrom:

Retamozo, Soledad ; Flores-Chavez, Alejandra ; Consuegra-Fernández, Marta...
Pharmacology & Therapeutics.  184 (2018)  - p. 81-97 , 2018
Link: https://doi.org/10.1016/..
 
?
7

Anti-Cyclic Citrullinated Peptide (Anti-CCP) and Anti-Mutat..:

Gonzalez-Lopez, Laura ; Rocha-Muñoz, Alberto Daniel ; Ponce-Guarneros, Manuel...
Journal of Immunology Research.  2014 (2014)  - p. 1-10 , 2014
Link: https://doi.org/10.1155/..
 
?
8

Mortality risk factors in primary Sjögren syndrome:a real-w..:

Brito-Zerón, Pilar ; Flores-Chávez, Alejandra ; Horváth, Ildiko Fanny...
https://research.rug.nl/en/publications/82e83f11-ffa7-4306-b4b8-57658f56748f.  , 2023
Link: https://hdl.handle.net/1..
 
?
9

Characterization and outcomes of 414 patients with primary ..:

Hernandez-Molina, Gabriela ; Kostov, Belchin ; Brito-Zeron, Pilar...
https://discovery.ucl.ac.uk/id/eprint/10160014/1/Isenberg_Hernandez%20%20tracking%20changes%2017%20feb%20MRC2.pdf.  , 2023
Link: https://discovery.ucl.ac..
 
?
10

Mortality risk factors in primary Sjögren syndrome: a real-..:

Brito-Zerón, Pilar ; Flores-Chávez, Alejandra ; Horváth, Ildikó Fanny...
eClinicalMedicine. -61 (2023), p. 1-16. -eClinicalMedicine. - 2589-5370.  , 2023
Link: https://hdl.handle.net/2..
 
?
11

Mortality risk factors in primary Sjögren syndrome : a real..:

Brito-Zerón, Pilar ; Flores-Chávez, Alejandra ; Horváth, Ildiko Fanny...
eClinicalMedicine, 2023, 61,.  , 2023
Link: http://urn.kb.se/resolve..
 
?
12

Characterization and outcomes of 414 patients with primary ..:

Hernandez-Molina, Gabriela ; Kostov, Belchin ; Brito-Zeron, Pilar...
https://research.rug.nl/en/publications/9e4d7ded-7a72-4d29-97c7-53271cb21de7.  , 2023
Link: https://hdl.handle.net/1..
 
?
13

Haemophagocytic syndrome and COVID-19:

Retamozo, Soledad ; Brito-Zerón, Pilar ; Sisó-Almirall, Antoni...
http://hdl.handle.net/10668/16895.  , 2021
Link: http://hdl.handle.net/10..
 
?
14

Immune-related adverse events of checkpoint inhibitors:

Ramos-Casals, Manuel ; Brahmer, Julie R ; Callahan, Margaret K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728094/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
15

IMMUNE-RELATED ADVERSE EVENTS INDUCED BY CANCER IMMUNOTHERA..:

Bingham, Clifton ; Suarez-Almazor, Maria ; Gottenberg, Jacques-Eric...
a056a55e-9fd4-4271-a3fe-d7e99cd27662.  , 2019
Link: https://doi.org/10.1136/..
 
1-15